|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-7-25
|
|
pubmed:abstractText |
Receptor for advanced glycation end products (RAGE) has recently been recognized as a cancer-associated protein responsible for cancer progression and metastasis in gastrointestinal cancers. The aim was to examine the role of RAGE in oral squamous cell carcinoma (OSCC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0309-0167
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
166-72
|
|
pubmed:meshHeading |
pubmed-meshheading:17593216-Aged,
pubmed-meshheading:17593216-Aged, 80 and over,
pubmed-meshheading:17593216-Carcinoma, Squamous Cell,
pubmed-meshheading:17593216-Disease-Free Survival,
pubmed-meshheading:17593216-Female,
pubmed-meshheading:17593216-Glycosylation End Products, Advanced,
pubmed-meshheading:17593216-Humans,
pubmed-meshheading:17593216-Immunohistochemistry,
pubmed-meshheading:17593216-Lymphatic Metastasis,
pubmed-meshheading:17593216-Male,
pubmed-meshheading:17593216-Middle Aged,
pubmed-meshheading:17593216-Mouth Neoplasms,
pubmed-meshheading:17593216-Multivariate Analysis,
pubmed-meshheading:17593216-Neoplasm Invasiveness,
pubmed-meshheading:17593216-Neoplasm Recurrence, Local,
pubmed-meshheading:17593216-Prognosis,
pubmed-meshheading:17593216-Receptors, Immunologic
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma.
|
|
pubmed:affiliation |
Department of Molecular Pathology, Nara Medical University School of Medicine, Kashihara, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
